SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Coram (CRH)--has the turnaround begun -- Ignore unavailable to you. Want to Upgrade?


To: leigh aulper who wrote (65)8/31/1999 4:07:00 PM
From: professor  Respond to of 85
 
Thank goodness CRH has been able to get out of the Aetna contract. Aetna was passing false information to Coram forcing them to provide services at a loss. The judge allowed Coram to terminate the contract overruling all of Aetna's attempt to delay and keep the relationship going. Coram has a very good case or the judge would not have made this ruling. In any case, this gets the monkey off of Coram's back and let's them get back to running the business. The prescription benefits management business is going well with substantial growth sequentially. Coram has $600 million in revenues and they have launched an internet product. The internet play could be huge. They have not announced their internet partner yet but Coram has a state of the art prescription filling facility to handle the new demand. CRH could get a lot of attention when they announce their partner. The stock is dirt cheap at 75 cents per share. A small turnaround with cause this stock to double or triple or quadruple easily.